The government has announced a £2bn per year funding boost for science and research which should herald benefits to those within the Golden Triangle.
The Cambridge-Oxford-London Golden Triangle is now firmly established as one of the world’s leading concentrations of biotechnology and life sciences.
In a post-Brexit environment, life sciences will have an increasingly important role to play in the economic growth of the UK. The rapid growth of the life sciences sector within the Golden Triangle places responsibility on the property sector to facilitate growth and nurture the development and investment necessary for its ongoing success.
Our latest research shows the unprecedented strength of Golden Triangle market and explores the differences between life sciences property in Cambridge, Oxford and London compared to their US counterparts.
Key findings include:
- Global bio-pharma industry turnover will increase to approximately $1.4 trillion by 2020.
- The Golden Triangle offers significant cost advantages over its US counterparts.
Total turnover in 2015 in the UK life sciences sector.
Available lab space in Oxford and Cambridge markets.
DOWNLOAD THE FULL REPORT